Active Not Recruiting PHASE2 INTERVENTIONAL 1-arm
NCT07090031
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer: A Single-arm, One Center Study
Sponsor: Qingdao Central Hospital
Interventions
TAS-102 in combination with oxaliplatin
Updated 1 time since 2025 Last updated: Jul 22, 2025 Started: Jul 1, 2025 Primary completion: Dec 1, 2027 Completion: May 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07090031, this PHASE2 trial focuses on EFS and pCR Rate and remains ongoing. Sponsored by Qingdao Central Hospital, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Active Not Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Qingdao Central Hospital
Data source: Qingdao Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .